Vancomycin in the Target Site Treatment of Intracranial Infection
Status:
Unknown status
Trial end date:
2018-12-01
Target enrollment:
Participant gender:
Summary
Vancomycin, a novel intravenously administered antibiotic, currently plays a key role in the
management of complicated multi-organism infections. However,current LC-MS/MS methods briefly
describe parameters and the only reported internal standard was sometimes difficult to
obtain. In our study,an updated LC-MS/MS method for the quantitative analysis of vancomycin
in human serum was developed.